Entirety Biomedical Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- (In Progress)
- Latest Deal Amount
-
$2M
- Investors
-
14
Entirety Biomedical General Information
Description
Manufacturer of high-performance absorbable metal implants intended to improve the quality of life with advanced bioabsorbable implant technology. The company facilitates the use of proprietary alloy technology to safely minimize implant life post-healing, provide simple and confident implantation, and ensure safe absorbability without increased risks of long-term complications, enabling patients to have a better life after implant while reducing surgical interventions and healthcare costs.
Contact Information
Website
www.entiretybio.comCorporate Office
- 4942 Dawn Avenue
- Suite 105
- East Lansing, MI 48823
- United States
Corporate Office
- 4942 Dawn Avenue
- Suite 105
- East Lansing, MI 48823
- United States
Entirety Biomedical Timeline
Entirety Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Early Stage VC | $2M | In Progress | Pre-Clinical Trials | |||
| 6. Early Stage VC | 31-Dec-2025 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 10-Oct-2025 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC | 26-Jun-2024 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 18-Mar-2024 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 15-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 1. Accelerator/Incubator | 18-Nov-2022 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Entirety Biomedical Comparisons
Industry
Financing
Details
Entirety Biomedical Competitors (4)
One of Entirety Biomedical’s 4 competitors is Syntellix, a Formerly VC-backed company based in Hannover, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Syntellix | Formerly VC-backed | Hannover, Germany | ||||
| Medical Magnesium | Formerly Accelerator/Incubator backed | Aachen, Germany | ||||
| Bioretec | Formerly PE-Backed | Tampere, Finland | ||||
| OSSIO | Venture Capital-Backed | Woburn, MA |
Entirety Biomedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Entirety Biomedical Patents
Entirety Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12661436-B2 | Bioabsorbable magnesium alloy with controlled multi-phase absorption | Active | 11-Apr-2024 | ||
| US-20250319237-A1 | Bioabsorbable magnesium alloy with controlled multi-phase absorption | Active | 11-Apr-2024 | ||
| US-20260192024-A1 | Bioabsorbable magnesium alloy with controlled multi-phase absorption | Pending | 11-Apr-2024 | ||
| US-12637742-B2 | Bioabsorbable magnesium alloy for implants with engineered absorption | Active | 15-Mar-2022 | ||
| US-20260117346-A1 | Bioabsorbable magnesium alloy for implants with engineered absorption | Pending | 15-Mar-2022 | C22C23/04 |
Entirety Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Entirety Biomedical Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ASPS Innovation & Entrepreneurship Hub | Accelerator/Incubator | |||
| Community Equity Partners | Angel Group | |||
| Mass Medical Angels | Angel Group | |||
| NuFund Venture Group | Angel Group | |||
| Revere Partners | Venture Capital | Minority |
Entirety Biomedical FAQs
-
When was Entirety Biomedical founded?
Entirety Biomedical was founded in 2022.
-
Where is Entirety Biomedical headquartered?
Entirety Biomedical is headquartered in East Lansing, MI.
-
What is the size of Entirety Biomedical?
Entirety Biomedical has 4 total employees.
-
What industry is Entirety Biomedical in?
Entirety Biomedical’s primary industry is Therapeutic Devices.
-
Is Entirety Biomedical a private or public company?
Entirety Biomedical is a Private company.
-
What is the current valuation of Entirety Biomedical?
The current valuation of Entirety Biomedical is .
-
What is Entirety Biomedical’s current revenue?
The current revenue for Entirety Biomedical is .
-
How much funding has Entirety Biomedical raised over time?
Entirety Biomedical has raised $2.25M.
-
Who are Entirety Biomedical’s investors?
ASPS Innovation & Entrepreneurship Hub, Community Equity Partners, Mass Medical Angels, NuFund Venture Group, and Revere Partners are 5 of 14 investors who have invested in Entirety Biomedical.
-
Who are Entirety Biomedical’s competitors?
Syntellix, Medical Magnesium, Bioretec, and OSSIO are competitors of Entirety Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
